Zubogesic Sublingual Tablet contains Piroxicam 20 mg, a nonsteroidal anti-inflammatory drug (NSAID) belonging to the oxicam class, indicated for the management of mild to moderate pain and inflammation associated with musculoskeletal disorders, rheumatoid arthritis, osteoarthritis, and acute gout. The sublingual formulation allows for rapid absorption through the oral mucosa, providing quicker onset of analgesic and anti-inflammatory effects compared to conventional oral tablets. Piroxicam exerts its therapeutic action by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, thereby reducing the synthesis of prostaglandins involved in pain, inflammation, and fever. Zubogesic is particularly useful in patients requiring prompt pain relief or those with difficulties swallowing tablets. The recommended dosage should be individualized based on the severity of symptoms and patient response, with careful consideration of contraindications such as hypersensitivity to NSAIDs, active gastrointestinal bleeding, or severe renal or hepatic impairment. Caution is advised in patients with cardiovascular risk factors, and concurrent use with other NSAIDs or anticoagulants should be avoided to minimize adverse effects. Common side effects may include gastrointestinal discomfort, dizziness, and skin reactions. Patients should be monitored regularly for signs of toxicity or adverse reactions during therapy.